PRIME MEDICINE INC (PRME:NASDAQ)
$2.97 0 (0%)
Analysed PRIME MEDICINE INC (PRME:NASDAQ) News Sources
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
03-03-2026
yahoo.com
Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates
03-03-2026
yahoo.com
Prime Medicine (PRME) Focuses on Liver Franchise With $191.4M Cash Runway
08-03-2026
yahoo.com
Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer
16-04-2026
yahoo.com
Prime Medicine (PRME) Appoints Svetlana Makhni as Chief Financial Officer
23-04-2026
yahoo.com
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
07-05-2026
yahoo.com
Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates
07-05-2026
yahoo.com
RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
07-05-2026
yahoo.com
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
Prime Medicine (PRME) Reports Q1 EPS
13-05-2026
yahoo.com
What is the current price of PRIME MEDICINE INC (PRME:NASDAQ)?
The current price of PRIME MEDICINE INC (PRME:NASDAQ) is $2.97.
PRIME MEDICINE INC (PRME:NASDAQ) absolute price change since previous trading day?
The absolute price change of PRIME MEDICINE INC (PRME:NASDAQ) since the previous trading day is $0.
PRIME MEDICINE INC (PRME:NASDAQ) percentage price change since previous trading day?
The percentage price change of PRIME MEDICINE INC (PRME:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for PRIME MEDICINE INC (PRME:NASDAQ)?
The most recent average sentiment score for PRIME MEDICINE INC (PRME:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for PRIME MEDICINE INC (PRME:NASDAQ)?
The most recent sentiment for PRIME MEDICINE INC (PRME:NASDAQ) is .
SEC-8K** Filing Available For PRIME MEDICINE INC (PRME:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.